If you have pain that radiates from your lower back down into your leg, you may have sciatica (also called lumbar radiculopathy) – a painful condition that affects millions of Australians each year. The most common cause of sciatica is a bulging disc in the lower spine, and the pain can be quite severe.
If you’re struggling with sciatica pain, you may qualify for the SALIENT Clinical Study, now being offered at select centres in Australia. The study is for an investigational, non-opioid single injection designed to relieve sciatica pain. Participants in the SALIENT study will receive care from a specialist pain doctor, and do not require a referral.
Sciatica is the name given to pain caused by irritation of the sciatic nerve, a long nerve that begins in the lower spine and extends down the back of each leg. The most common cause of sciatica is a bulging disc in the spine, but there may be other causes.
Sciatica pain varies from person to person. The location of the pain can be anywhere along the path of the sciatic nerve - ranging from the lower back and buttock, down behind the thigh and into the calf. The pain can feel like a cramp or may be excruciating and can make sitting or standing very difficult. For others, it is a sharp or shooting pain, or a “pins and needles” feeling.
Right now, doctors at select centres in Australia are conducting the SALIENT Clinical Study. The study is evaluating SX600 – an investigational, non-opioid single injection designed to provide long-term relief of sciatica pain. SX600 is a sustained-release product, which is designed to deliver small doses of a corticosteroid to the inflamed nerve over a period of time.
Clinical trials are research investigations in which people volunteer to test new treatments, interventions or tests as a means to prevent, detect, treat or manage various diseases or medical conditions. Some investigations look at how people respond to a new intervention and what side effects might occur. This helps to determine if a new intervention works, if it is safe, and if it is better than the interventions that are already available. Clinical trials contribute enormously to the community and to medical advancements throughout the world. Although there are many types of clinical trials, all must conform to strict rules set by the Therapeutics Goods Administration (TGA). These rules help protect the rights and safety of those who volunteer to take part in clinical trials.
If you’re struggling with sciatica pain in your leg, you may qualify for the SALIENT Clinical Study, now being offered at select centres throughout Australia. The study is for an investigational, non-opioid single injection designed to relieve sciatica pain. If you qualify and choose to join the SALIENT study, you will receive:
See If You Qualify
To see if you might qualify for the SALIENT Study, and to get connected with your local study centre to learn more, please take the questionnaire below: